To provide that the actuarial value of the prescription drug benefits offered to Medicare eligible enrollees by a plan under the Federal employees health benefits program shall be at least equal to the actuarial value of the prescription drug benefits offered by such plan to its enrollees generally.
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Provides that a health insurance contract shall not be made or a health insurance plan approved under the Federal Employees Health Benefits Program which does not offer to Medicare eligible enrollees prescription drug benefits the actuarial value of which is at least equal to the actuarial value of such benefits which are offered to enrollees under a plan generally.
Directs the Office of Personnel Management to establish processes and methods for determining the actuarial value of prescription drug benefits.
Committee on Governmental Affairs referred to Subcommittee on Financial Management, the Budget, and International Security.
Introduced in House
Introduced in House
Sponsor introductory remarks on measure. (CR E1411)
Referred to the House Committee on Government Reform.
Mr. Davis, Tom moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H6303-6309)
DEBATE - The House proceeded with forty minutes of debate on H.R. 2631.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H6303-6304)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6303-6304)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Governmental Affairs.
Committee on Governmental Affairs referred to Subcommittee on Financial Management, the Budget, and International Security.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line